Richard Glen Ellenbogen

This inventor holds 10 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignees: Elwha LLC, University of Washington, Fred Hutchinson Cancer Center. Active years: 2014-2025.

USPTO Granted Patents = 10 (Patent Applications = 11)

% Patents Active = 50.0

EPO Patents = 1

Average Co-Inventor Count = 12.7

ph-index = 4

Forward Citations = 50(Granted Patents)

Company Filing History:

University of Washington

patents

1 out of 308

Fred Hutchinson Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12329773 - Oxygen reactive polymers for treatment of traumatic brain injury (2025-06-17),

2. 11065272 - Oxygen reactive polymers for treatment of traumatic brain injury (2021-07-20),

3. 10181247 - System and method for impact prediction and proximity warning (2019-01-15),

4. 10086251 - Systems and methods for determining penalties (2018-10-02),

5. 9788588 - Helmet airbag system (2017-10-17),

6. 9784730 - [object Object] (2017-10-10),

7. 9730482 - System and method for airbag deployment and inflation (2017-08-15),

8. 9396641 - System and method for impact prediction and proximity warning (2016-07-19),

9. 9384645 - System and method for impact prediction and proximity warning (2016-07-05),

10. 8778310 - Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer (2014-07-15),

Title: Innovator Spotlight: Richard Glen Ellenbogen

Introduction:

Richard Glen Ellenbogen is a prolific inventor based in Seattle, WA, with a notable track record in creating solutions for traumatic brain injuries and impact prediction technologies. With a total of 9 patents to his name, Ellenbogen is recognized for his contributions to the field of medical innovations and predictive analytics.

Latest Patents:

Ellenbogen's latest patents showcase his expertise in developing cutting-edge solutions for the treatment of traumatic brain injuries. His Oxygen Reactive Polymers for Traumatic Brain Injury propose methods and compositions utilizing multi-functional oxygen reactive polymers for scavenging reactive oxygen species. Additionally, his System and Method for Impact Prediction and Proximity Warning introduces a predictive system that warns users of potential impacts based on motion data.

Career Highlights:

Having worked with Elwha LLC and the University of Washington, Ellenbogen has honed his skills in innovation and research. His contributions to these institutions have further solidified his reputation as a forward-thinker in the realms of medical advancements and impact prediction technologies.

Collaborations:

Throughout his career, Ellenbogen has collaborated with esteemed colleagues such as Paul G Allen and Philip V Bayly. These partnerships have been instrumental in bringing his ideas to fruition and expanding the impact of his inventions in the relevant industries.

Conclusion:

Richard Glen Ellenbogen's dedication to enhancing medical treatments and predictive analytics through his innovative patents underscores his commitment to making a positive difference in society. His continued pursuit of groundbreaking solutions cements his position as a leading inventor in the field, with a promising trajectory for future advancements and collaborations.